Mark Froimson

Insider

First SEC filing: June 12, 2026 · Latest: June 12, 2026

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.

Insider at

PCRX buying Aug. 12, 2024

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 21 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

21 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
June 10, 2026	PCRX	A	10,891	—	—	10,891 Direct	—	Acquired	(price as of 2026-08-20)
June 10, 2026	PCRX	A	6,405	—	—	26,541 Direct	+31.81%	Acquired	(price as of 2026-08-20)
June 11, 2025	PCRX	A	6,163	—	—	20,636 Direct	+42.58%	Acquired	(price as of 2026-08-20)
June 11, 2025	PCRX	A	11,279	—	—	11,279 Direct	—	Acquired	(price as of 2026-08-20)
Aug. 12, 2024	PCRX	P	1,400	$11.58	$16,212	14,473 Direct	+10.71%	Acquired	108.0% (price as of 2026-08-20)
June 12, 2024	PCRX	A	5,230	—	—	13,073 Direct	+66.68%	Acquired	(price as of 2026-08-20)
June 12, 2024	PCRX	A	12,179	—	—	12,179 Direct	—	Acquired	(price as of 2026-08-20)
June 14, 2023	PCRX	A	12,925	—	—	12,925 Direct	—	Acquired	(price as of 2026-08-20)
June 14, 2023	PCRX	A	1,775	—	—	7,843 Direct	+29.25%	Acquired	(price as of 2026-08-20)
June 8, 2022	PCRX	A	8,225	—	—	8,225 Direct	—	Acquired	(price as of 2026-08-20)
June 8, 2022	PCRX	A	1,160	—	—	6,068 Direct	+23.63%	Acquired	(price as of 2026-08-20)
May 9, 2022	PCRX	S	1,000	$59.37	$59,370	4,908 Direct	-16.93%	Disposed	-59.4% (price as of 2026-08-20)
Dec. 17, 2021	PCRX	G	400	—	—	5,908 Direct	-6.34%	Disposed	(price as of 2026-08-20)
June 9, 2021	PCRX	A	1,066	—	—	6,308 Direct	+20.34%	Acquired	(price as of 2026-08-20)
June 9, 2021	PCRX	A	7,626	—	—	7,626 Direct	—	Acquired	(price as of 2026-08-20)
March 15, 2021	PCRX	S	734	$72.26	$53,039	5,242 Direct	-12.28%	Disposed	-66.7% (price as of 2026-08-20)
June 9, 2020	PCRX	A	8,027	—	—	8,027 Direct	—	Acquired	(price as of 2026-08-20)
June 9, 2020	PCRX	A	1,260	—	—	5,976 Direct	+26.72%	Acquired	(price as of 2026-08-20)
Dec. 16, 2019	PCRX	G	300	—	—	4,716 Direct	-5.98%	Disposed	(price as of 2026-08-20)
June 5, 2019	PCRX	A	8,437	—	—	8,437 Direct	—	Acquired	(price as of 2026-08-20)
June 5, 2019	PCRX	A	4,134	—	—	5,016 Direct	+468.71%	Acquired	(price as of 2026-08-20)
June 13, 2018	PCRX	A	4,693	—	—	4,693 Direct	—	Acquired	(price as of 2026-08-20)
June 13, 2018	PCRX	A	782	—	—	882 Direct	+782.00%	Acquired	(price as of 2026-08-20)
Aug. 8, 2017	PCRX	P	100	$37.13	$3,713	100 Direct	—	Acquired	-35.1% (price as of 2026-08-20)
June 14, 2017	PCRX	A	8,144	—	—	8,144 Direct	—	Acquired	(price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
June 10, 2026	PCRX	Stock Option (Right to Buy)	Common Stock (10,891)	$23.42	June 10, 2036	10,891	Acquired
June 11, 2025	PCRX	Stock Option (Right to Buy)	Common Stock (11,279)	$24.34	June 11, 2035	11,279	Acquired
June 12, 2024	PCRX	Stock Option (Right to Buy)	Common Stock (12,179)	$28.68	June 12, 2034	12,179	Acquired
June 14, 2023	PCRX	Stock Option (Right to Buy)	Common Stock (12,925)	$38.74	June 14, 2033	12,925	Acquired
June 8, 2022	PCRX	Stock Option (Right to Buy)	Common Stock (8,225)	$59.39	June 8, 2032	8,225	Acquired
June 9, 2021	PCRX	Stock Option (Right to Buy)	Common Stock (7,626)	$60.96	June 9, 2031	7,626	Acquired
June 9, 2020	PCRX	Stock Option (Right to Buy)	Common Stock (8,027)	$47.65	June 9, 2030	8,027	Acquired
June 5, 2019	PCRX	Stock Option (Right to Buy)	Common Stock (8,437)	$43.54	June 5, 2029	8,437	Acquired
June 13, 2018	PCRX	Stock Option (Right to Buy)	Common Stock (4,693)	$38.35	June 13, 2028	4,693	Acquired
June 14, 2017	PCRX	Stock Option (Right to Buy)	Common Stock (8,144)	$44.20	June 14, 2027	8,144	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).